Show simple item record

dc.contributorBashrahil, K.A.EN
dc.contributorBingouth, A.S.EN
dc.contributorBaruzaig, A.S.EN
dc.date.accessioned2014-06-17T09:00:46Z
dc.date.available2014-06-17T09:00:46Z
dc.date.issued2010EN
dc.identifier.issn1020-3397EN
dc.identifier.otherhttp://applications.emro.who.int/emhj/V16/02/16_2_2010_0146_0150.pdfEN
dc.identifier.urihttp://www.who.int/iris/handle/10665/117832
dc.description146-150EN
dc.description.abstractMalaria is one of the top health problems in Yemen. This study was done to evaluate the availability and prescribing of antimalarial drugs in Al-Mukalla city, based on the treatment guidelines of the National Malaria Control Programme [‎NMCP]‎. Chloroquine, quinine and sulfadoxine/pyrimethamine were the most available and prescribed antimalarial drugs in all 60 pharmacies [‎government and private]‎ in the city. Of 42 prescriptions analysed, 54.2% did not comply with NMCP guidelines on appropriate dose and duration, especially those prescribed by GPs: 16.7% contained more than 1 antimalarial drug. More efforts are needed to educate physicians about the NMCP treatment guidelines and to deter pharmacies from random selling of antimalarial drugsEN
dc.language.isoenEN
dc.subjectDrug PrescriptionsEN
dc.subjectGuideline AdherenceEN
dc.subjectPharmacyEN
dc.subjectQuestionnairesEN
dc.subject.meshAntimalarialsEN
dc.titleAntimalarial drugs: availability and mode of prescribing in Mukalla, YemenEN
dc.relation.ispartofjournalEMHJ - Eastern Mediterranean Health Journal, 16 (‎2)‎, 146-150, 2010


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record